Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,348
archived clinical trials in
Podiatry

A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/8/2017
Phoenix Medical Research
mi
from
Miami, FL
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/8/2017
Phoenix Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/8/2017
Orthopedic Research Institute
mi
from
West Palm Beach, FL
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/8/2017
Orthopedic Research Institute
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/8/2017
Aiyan Diabetes Center
mi
from
Martinez, GA
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/8/2017
Aiyan Diabetes Center
mi
from
Martinez, GA
Click here to add this to my saved trials
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/8/2017
Clinical Research Medical Center
mi
from
Las Vegas, NV
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/8/2017
Clinical Research Medical Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/8/2017
Clinical Research Associates of Central PA
mi
from
Altoona, PA
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/8/2017
Clinical Research Associates of Central PA
mi
from
Altoona, PA
Click here to add this to my saved trials
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/8/2017
Houston Foot & Ankle
mi
from
Houston, TX
A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/8/2017
Houston Foot & Ankle
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Birmingham, AL
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Encinitas, CA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
San Diego, CA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
San Diego, CA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
San Francisco, CA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Santa Rosa, CA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Denver, CO
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Miramar, FL
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Miramar, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Newnan, GA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Newnan, GA
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Boise, ID
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Boise, ID
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Evansville, IN
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Clinton TWP, MI
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Clinton TWP, MI
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Fridley, MN
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Fridley, MN
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Rochester, NY
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Portland, OR
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Portland, OR
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Knoxville, TN
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Nashville, TN
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Austin, TX
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
College Station, TX
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Lynchburg, VA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Norfolk, VA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated:  3/22/2017
Clinical Research Facility
mi
from
Spokane, WA
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis
Status: Enrolling
Updated: 3/22/2017
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Birmingham, AL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Mesa, AZ
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Tucson, AZ
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Jonesboro, AR
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Bakersfield, CA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Fresno, CA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Boynton Beach, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Hialeah, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Miami, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
North Miami Beach, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
North Miami Beach, FL
Click here to add this to my saved trials